Arrowpoint Investment Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,600
Closed -$265K 476
2025
Q1
$265K Buy
1,600
+600
+60% +$93.9K 0.03% 618
2024
Q4
$145K Buy
+1,000
New +$155K 0.03% 489

Other funds holding JNJ

Arrowpoint Investment Partners's JNJ Position: Q1 2026 in Review

Arrowpoint Investment Partners reduced its Johnson & Johnson (JNJ) stake by 97% in Q1 2026, selling an estimated $71.3M and leaving 7,902 shares worth $1.93M. The position accounts for 1.72% of the portfolio, ranked #15.

Arrowpoint Investment Partners first reported a position in JNJ in Q4 2025 and has held it in 2 quarters since. The position peaked at $65M in Q4 2025. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Arrowpoint Investment Partners held 7,902 shares of Johnson & Johnson worth $1.93M as of Q1 2026.
  • Arrowpoint Investment Partners sold 306,027 Johnson & Johnson shares in Q1 2026, an estimated $71.3M.
  • Johnson & Johnson made up 1.72% of Arrowpoint Investment Partners's portfolio in Q1 2026, its #15 holding.
  • Arrowpoint Investment Partners first reported a position in Johnson & Johnson in Q4 2025 and has held it in 2 quarters since.
  • Arrowpoint Investment Partners's Johnson & Johnson position peaked at $65M in Q4 2025.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Arrowpoint Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.